Ian A Shiels Selected Research

Ian A Shiels Research Topics

Disease

7	Reperfusion Injury 12/2006 - 04/2002
5	Wounds and Injuries (Trauma) 12/2006 - 04/2002
5	Neutropenia 08/2006 - 04/2002
5	Edema (Dropsy) 08/2005 - 04/2002
3	Inflammation (Inflammations) 01/2016 - 01/2006
3	Necrosis 03/2011 - 11/2002
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2005 - 11/2003
3	Colitis 08/2005 - 11/2003
3	Ischemia 01/2004 - 04/2002
2	Neoplasms (Cancer) 01/2021 - 01/2011
2	Arthritis (Polyarthritis) 03/2011 - 09/2002
2	Body Weight (Weight, Body) 08/2005 - 05/2005
2	Hypotension (Low Blood Pressure) 09/2003 - 11/2002
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Tachycardia (Tachyarrhythmias) 02/2014
1	Atherosclerotic Plaque (Atheroma) 07/2011
1	Atherosclerosis 07/2011
1	Rheumatoid Arthritis 03/2011
1	Dog Diseases (Disease, Canine) 03/2010
1	Shock 08/2006
1	Burns 08/2006
1	Sepsis (Septicemia) 08/2006
1	Lung Injury 08/2006
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2006
1	Hemorrhagic Shock 08/2006
1	Huntington Disease (Huntington's Disease) 07/2006
1	Proteinuria 01/2004
1	Weight Gain 11/2003
1	Hemorrhage 01/2003
1	Hematuria 01/2003
1	Bradycardia 11/2002

Drug/Important Bio-Agent (IBA)

9	Anaphylatoxin C5a ReceptorIBA 01/2016 - 04/2002
8	Complement System Proteins (Complement)IBA 01/2021 - 04/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 04/2002
5	AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA 01/2006 - 04/2002
4	Peroxidase (Myeloperoxidase)IBA 05/2005 - 01/2003
3	Secretory Phospholipases A2IBA 03/2011 - 09/2003
3	Cyclic PeptidesIBA 01/2006 - 04/2002
3	Pharmaceutical PreparationsIBA 08/2005 - 11/2003
3	Sulfonic AcidsIBA 08/2005 - 11/2003
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2003 - 04/2002
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2011
2	Atenolol (Tenormin)FDA LinkGeneric 01/2016 - 02/2014
2	EnzymesIBA 03/2011 - 05/2005
2	Infliximab (Remicade)FDA Link 03/2011 - 11/2003
2	Prednisolone (Predate)FDA LinkGeneric 03/2011 - 11/2003
2	AntigensIBA 03/2011 - 09/2002
2	Group II Phospholipases A2IBA 03/2011 - 05/2005
2	hydrocinnamate- cyclo(ornithyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)IBA 07/2006 - 08/2005
2	Factor VaIBA 08/2005 - 04/2002
2	CreatinineIBA 01/2004 - 01/2003
1	Tyr(65)-Phe(67)-Pro(69,71)-Ala(73)- (65-74) complement C5aIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Complement Receptors (Complement Receptor)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 07/2011
1	Complement C5a (Complement 5a)IBA 07/2011
1	Leflunomide (Arava)FDA LinkGeneric 03/2011
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2011
1	Etanercept (Enbrel)FDA Link 03/2010
1	carprofen FDA Link 03/2010
1	cobra venom factorIBA 08/2006
1	3-nitropropionic acidIBA 07/2006
1	Dihydrotachysterol (AT 10)IBA 08/2005
1	sym-trinitrobenzeneIBA 08/2005
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 05/2005
1	Phospholipases (Phospholipase)IBA 05/2005
1	AcidsIBA 05/2005
1	cyclohexylalanineIBA 11/2003
1	Celecoxib (Celebrex)FDA Link 09/2003
1	zafirlukast (Accolate)FDA LinkGeneric 09/2003
1	Leukotriene C4IBA 09/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2003
1	Ethanol (Ethyl Alcohol)IBA 01/2003
1	pirfenidoneIBA 11/2002
1	Ibuprofen (Motrin)FDA LinkGeneric 09/2002
1	methylated bovine serum albumin (MBSA)IBA 09/2002
1	HaptoglobinsIBA 04/2002
1	phenylalanyl(ornithinyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)IBA 04/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2006 - 05/2004
1	Therapeutics 03/2011
1	Intravenous Infusions 08/2006
1	Topical Administration 01/2006
1	Oral Administration 01/2006
1	Controlled Hypotension 01/2006
1	Intra-Articular Injections 09/2002